AI-Powered Tempus Inks New Multi-Year Merck Deal

Tempus AI Inc. (NASDAQ:TEM) on Tuesday inked a strategic collaboration agreement with Merck & Co. Inc. (NYSE:MRK) aimed at accelerating AI-driven precision medicine.The stock’s decline comes as broader markets experienced significant sell-offs, with major indices like the S&P 500 and Nasdaq both trading lower today.Tempus announced an expanded, multi-year collaboration with Merck to enhance the discovery and development of precision medicine biomarkers.The partnership will leverage Tempus’ extensive library ...